Published in Lancet Infect Dis on April 30, 2013
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis (2016) 1.58
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011. Antimicrob Agents Chemother (2013) 1.09
PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance. J Clin Microbiol (2014) 1.00
Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol (2014) 1.00
Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev (2014) 0.99
Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study. Crit Care (2016) 0.93
Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative. J Clin Microbiol (2015) 0.88
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing. Clin Infect Dis (2015) 0.88
Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs during Testing of Serum Samples. J Clin Microbiol (2015) 0.85
Evaluation of a commercially developed semiautomated PCR-surface-enhanced raman scattering assay for diagnosis of invasive fungal disease. J Clin Microbiol (2014) 0.85
Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update. Adv Hematol (2014) 0.83
Facilitating surveillance of pulmonary invasive mold diseases in patients with haematological malignancies by screening computed tomography reports using natural language processing. PLoS One (2014) 0.83
Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species. Microb Biotechnol (2016) 0.82
Dual Invasive Infection with Phaeoacremonium parasiticum and Paraconiothyrium cyclothyrioides in a Renal Transplant Recipient: Case Report and Comprehensive Review of the Literature of Phaeoacremonium Phaeohyphomycosis. J Clin Microbiol (2015) 0.81
Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosis. Front Microbiol (2015) 0.81
The end of the road for empirical antifungal treatment? Lancet Infect Dis (2013) 0.80
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia. PLoS One (2015) 0.78
Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Aspergillus, Scedosporium, and Fusarium spp. in the Australian Clinical Setting. J Clin Microbiol (2016) 0.78
Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases. Eur J Clin Microbiol Infect Dis (2015) 0.78
Hematopoietic stem cell transplantation-50 years of evolution and future perspectives. Rambam Maimonides Med J (2014) 0.77
Comparison of Performance Characteristics of Aspergillus PCR in Testing a Range of Blood-Based Samples in Accordance with International Methodological Recommendations. J Clin Microbiol (2016) 0.76
Antifungal stewardship considerations for adults and pediatrics. Virulence (2016) 0.76
Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status. Curr Fungal Infect Rep (2017) 0.76
Granulocyte transfusions in the management of invasive fungal infections. Br J Haematol (2017) 0.75
Molecular Diagnostic Testing for Aspergillus. J Clin Microbiol (2016) 0.75
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia. Heart Lung Vessel (2014) 0.75
Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013-2014. PLoS One (2016) 0.75
Epidemiology of invasive fungal disease in lymphoproliferative disorders. Haematologica (2015) 0.75
Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal Model. J Clin Microbiol (2016) 0.75
Factors predicting prolonged empirical antifungal treatment in critically ill patients. Ann Clin Microbiol Antimicrob (2014) 0.75
Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study. Can J Infect Dis Med Microbiol (2015) 0.75
Challenges in microbiological diagnosis of invasive Aspergillus infections. F1000Res (2017) 0.75
Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China. Clinicoecon Outcomes Res (2016) 0.75
Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4). Turk J Haematol (2015) 0.75
Recent developments in the management of invasive fungal infections in patients with oncohematological diseases. Ther Adv Hematol (2016) 0.75
Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis. PLoS One (2014) 0.75
Treatment options in Invasive Aspergillosis. Curr Treat Options Infect Dis (2014) 0.75
Reporting of pre-enrolment screening with randomized clinical trials: A small item that could impact a big difference. Perspect Clin Res (2015) 0.75
Prospective biomarker screening for the diagnosis of invasive aspergillosis in high-risk paediatric patients. J Clin Microbiol (2016) 0.75
Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group. Support Care Cancer (2017) 0.75
An analytical and clinical evaluation of the PathoNostics AsperGenius® Assay for the detection of invasive aspergillosis and resistance to azole antifungal drugs direct from plasma samples. J Clin Microbiol (2017) 0.75
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis (2010) 11.65
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med (2006) 6.90
Youth risk behavior surveillance--United States, 2013. MMWR Surveill Summ (2014) 6.17
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res (2008) 4.84
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet (2011) 3.41
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study. Blood (2013) 3.23
Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure. J Clin Oncol (2009) 3.14
A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med (2013) 2.90
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.36
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood (2005) 2.23
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood (2012) 2.21
Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med (2015) 2.18
Adverse event rates in congenital cardiac catheterization - a multi-center experience. Catheter Cardiovasc Interv (2010) 2.15
Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res (2002) 2.13
Bronchoscopic guidance of endovascular stenting limits airway compression. Catheter Cardiovasc Interv (2014) 2.07
Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration. Antimicrob Agents Chemother (2012) 2.05
Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. Blood (2011) 1.88
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis (2013) 1.76
The use of nonhuman primate models in HIV vaccine development. PLoS Med (2008) 1.73
Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust (2010) 1.68
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol (2013) 1.68
Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring. Antimicrob Agents Chemother (2012) 1.67
Echinocandin antifungal drugs in fungal infections: a comparison. Drugs (2011) 1.67
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica (2009) 1.65
Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect (2002) 1.60
Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc (2013) 1.59
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations. Blood (2004) 1.57
Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One (2011) 1.57
A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays. Med Mycol (2002) 1.56
Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke (2004) 1.55
High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology (2008) 1.55
The gene Sr33, an ortholog of barley Mla genes, encodes resistance to wheat stem rust race Ug99. Science (2013) 1.55
Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med (2008) 1.50
Surveillance for catheter-associated bloodstream infection in hematology units: quantifying the characteristics of a practical case definition. Infect Control Hosp Epidemiol (2008) 1.47
Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood (2003) 1.44
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. Blood (2008) 1.42
Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol (2007) 1.40
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood (2002) 1.39
Mannose-binding lectin deficiency does not increase the prevalence of Helicobacter pylori seropositivity. Eur J Gastroenterol Hepatol (2007) 1.38
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother (2010) 1.34
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother (2006) 1.34
X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch. J Biol Chem (2003) 1.33
Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory. PLoS One (2012) 1.31
Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol (2003) 1.30
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol (2012) 1.28
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion. Blood (2004) 1.27
Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics (2009) 1.25
Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv (2011) 1.23
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. Clin Infect Dis (2009) 1.22
Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutase. Eukaryot Cell (2006) 1.21
Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia. Blood (2009) 1.21
Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin Cancer Res (2008) 1.20
Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools. Curr Opin Infect Dis (2011) 1.20
Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol (2007) 1.19
Antifungal therapy in invasive fungal infections. Curr Opin Pharmacol (2010) 1.18
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period. Haematologica (2011) 1.17
Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol (2009) 1.17
FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells. Autophagy (2011) 1.16
Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia). Cancer Causes Control (2005) 1.16
Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum (2007) 1.15
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J Rheumatol (2004) 1.15
secA1 gene sequence polymorphisms for species identification of Nocardia species and recognition of intraspecies genetic diversity. J Clin Microbiol (2010) 1.15
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells (2009) 1.14
Irreversible intrapulmonary vascular changes after pulmonary vein stenosis complicating catheter ablation for atrial fibrillation. Cardiovasc Pathol (2007) 1.13
Simultaneous detection and identification of Candida, Aspergillus, and Cryptococcus species by reverse line blot hybridization. J Clin Microbiol (2006) 1.12
Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma. BMC Cancer (2005) 1.12
Antifungal agents. Med J Aust (2007) 1.12
Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. J Biol Chem (2007) 1.11
Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol (2008) 1.10
Identification of metabolites of importance in the pathogenesis of pulmonary cryptococcoma using nuclear magnetic resonance spectroscopy. Microbes Infect (2003) 1.10
A combined sEMG and accelerometer system for monitoring functional activity in stroke. IEEE Trans Neural Syst Rehabil Eng (2009) 1.10
Secretion of cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol (GPI) anchor. Biochem J (2005) 1.10
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*. Br J Haematol (2006) 1.09
Early establishment of gamma-herpesvirus latency: implications for immune control. J Immunol (2005) 1.09
Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis (2012) 1.09
Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy. Circulation (2010) 1.08
RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia. Autophagy (2009) 1.08
Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices. Support Care Cancer (2008) 1.07
Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant (2008) 1.07
Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004. Biol Blood Marrow Transplant (2007) 1.07
Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray. Br J Haematol (2006) 1.07
Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther (2011) 1.07